Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Consumer Resources

Clinical Research/R&D

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Ebola Solidifies Some Lawmakers’ Commitment To Biomedical Research Spending

Roll Call: Ebola Drives Interest in More Biomedical Research “…Top appropriators from both parties say they are committed to investing in biomedical research, particularly the National Institutes of Health. But the parties have not agreed on how to boost that funding, and lawmakers also have criticized some of the government’s…

Epidemiologists, Gene Researchers Hunt For Clues On Ebola’s Spread

IRIN: Ebola: Where next and how bad? “In the past few months huge amounts of time and energy have been spent trying to second-guess the progress of the Ebola outbreak in West Africa. Where will the next hotspot be? … Predictions so far have been off the mark, so better…

HIV Evolving Into Less Virulent Form, Scientists Report

Al Jazeera: Study: HIV causing AIDS ‘weakening over time’ “The rapid evolution of HIV, a human immunodeficiency virus, is slowing its ability to cause AIDS, according to a study of more than 2,000 women in Africa…” (12/2). BBC News: HIV evolving ‘into milder form’ “…The findings in Proceedings of the…

Growing Global Vaccine Market Helping Spur Drug Companies To Pursue Ebola Vaccine

The New Yorker: The Race for an Ebola Vaccine “…So why this race to create an Ebola vaccine among Merck, GlaxoSmithKline, and Johnson & Johnson — three of the world’s biggest drug manufacturers? … [O]ver the past several years, companies have realized that the difficulties of making vaccines could be…

Merck Purchasing Rights To NewLink’s Experimental Ebola Vaccine

News outlets report on a deal between pharmaceutical companies Merck and NewLink to develop, test, and market a potential Ebola vaccine. NPR: Merck Partners With NewLink To Speed Up Work On Ebola Vaccine “[Monday] NewLink Genetics said it has made a deal with drugmaker Merck to research, develop, manufacture, and…